发明授权
US06987113B2 Tyrosine kinase inhibitors 失效
酪氨酸激酶抑制剂

Tyrosine kinase inhibitors
摘要:
The present invention relates to novel 3-hetero-arylideneazaindolin-2-one compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.
公开/授权文献
信息查询
0/0